| 30/06/23 | 17:00:00 | 30 Jun 2023 | | Total Voting Rights |
| 28/06/23 | 12:01:18 | 28 Jun 2023 | | Result of AGM |
| 12/06/23 | 14:15:46 | 12 Jun 2023 | | Total Voting Rights |
| 12/06/23 | 07:00:05 | 12 Jun 2023 | | Subscription to raise £350,000 |
| 05/06/23 | 12:35:39 | 5 Jun 2023 | | Posting of Annual Report and Notice of AGM |
| 15/05/23 | 13:42:12 | 15 May 2023 | | Update on Royalty Sharing Agreement in AZD1656 |
| 27/04/23 | 07:00:04 | 27 Apr 2023 | | Results for the year ended 31 December 2022 |
| 24/04/23 | 07:00:06 | 24 Apr 2023 | | New Research Agreement with the University of York |
| 30/03/23 | 11:05:31 | 30 Mar 2023 | | Second Price Monitoring Extn |
| 30/03/23 | 11:00:09 | 30 Mar 2023 | | Price Monitoring Extension |
| 17/03/23 | 16:35:19 | 17 Mar 2023 | | Price Monitoring Extension |
| 13/03/23 | 09:00:14 | 13 Mar 2023 | | Price Monitoring Extension |
| 07/03/23 | 07:00:06 | 7 Mar 2023 | | Issue of Options in lieu of salary increases |
| 22/02/23 | 07:52:55 | 22 Feb 2023 | | Holding(s) in Company |
| 06/02/23 | 07:02:20 | 6 Feb 2023 | | Holding(s) in Company |
| 31/01/23 | 17:00:01 | 31 Jan 2023 | | Total Voting Rights |
| 24/01/23 | 12:48:49 | 24 Jan 2023 | | Holding(s) in Company |
| 20/12/22 | 15:17:17 | 20 Dec 2022 | | Update re. timing of Admission |
| 19/12/22 | 07:00:06 | 19 Dec 2022 | | Put Option re AZD1656 & £115,586 Subscription |
| 23/11/22 | 08:04:13 | 23 Nov 2022 | | Clinical Study for Lung Cancer Detection in China |
| 09/11/22 | 07:00:07 | 9 Nov 2022 | | Conduit Pharmaceuticals Proposed Listing |
| 31/10/22 | 17:00:06 | 31 Oct 2022 | | Total Voting Rights |
| 04/10/22 | 08:00:02 | 4 Oct 2022 | | Admission and Total Voting Rights |
| 30/09/22 | 17:00:06 | 30 Sept 2022 | | Total Voting Rights |
| 29/09/22 | 15:49:11 | 29 Sept 2022 | | Issue of Consideration Shares & Option Exercise |
| 28/09/22 | 15:05:04 | 28 Sept 2022 | | Holding(s) in Company |
| 28/09/22 | 07:00:09 | 28 Sept 2022 | | Interim results |
| 26/09/22 | 08:00:04 | 26 Sept 2022 | | Admission and Total Voting Rights |
| 21/09/22 | 11:23:11 | 21 Sept 2022 | | Subscription, Facility & Publication of Prospectus |
| 18/08/22 | 09:21:23 | 18 Aug 2022 | | Arcadia Clinical Trial Results Published |
| 10/08/22 | 16:41:01 | 10 Aug 2022 | | Second Price Monitoring Extn |
| 10/08/22 | 16:36:05 | 10 Aug 2022 | | Price Monitoring Extension |
| 05/07/22 | 07:00:05 | 5 Jul 2022 | | Update on Development of Proprietary Antibodies |
| 27/06/22 | 11:52:38 | 27 Jun 2022 | | Result of AGM |
| 16/06/22 | 07:00:04 | 16 Jun 2022 | | Marketing Agreement to Enhance Expansion in the US |
| 01/06/22 | 07:00:11 | 1 Jun 2022 | | Posting of Annual Report and Notice of AGM |
| 30/05/22 | 07:00:08 | 30 May 2022 | | Results for the year ended 31 December 2021 |
| 06/05/22 | 09:05:48 | 6 May 2022 | | Second Price Monitoring Extn |
| 06/05/22 | 09:00:33 | 6 May 2022 | | Price Monitoring Extension |
| 06/05/22 | 07:00:06 | 6 May 2022 | | Strategic Alliance re lung cancer detection in USA |
| 11/04/22 | 07:00:08 | 11 Apr 2022 | | Further Research Agreement with University of York |
| 31/03/22 | 17:28:59 | 31 Mar 2022 | | Holding(s) in Company |
| 22/03/22 | 16:40:55 | 22 Mar 2022 | | Second Price Monitoring Extn |
| 22/03/22 | 16:35:33 | 22 Mar 2022 | | Price Monitoring Extension |
| 22/03/22 | 14:05:33 | 22 Mar 2022 | | Second Price Monitoring Extn |
| 22/03/22 | 14:00:34 | 22 Mar 2022 | | Price Monitoring Extension |
| 07/03/22 | 07:00:09 | 7 Mar 2022 | | Positive outcomes from Arcadia Trial re AZD1656 |
| 28/02/22 | 17:00:01 | 28 Feb 2022 | | Total Voting Rights |
| 18/02/22 | 15:56:41 | 18 Feb 2022 | | Holding(s) in Company |
| 16/02/22 | 15:23:22 | 16 Feb 2022 | | Total Voting Rights |
